Lilly Commits Additional $4.5 Billion in Indiana Manufacturing Sites
The company said the expansion will support genetic medicines and weight-loss drugs, and bring total Indiana capital commitments since 2020 above $21 billion.
- On Wednesday, Eli Lilly and Company announced a $4.5 billion investment across two Lebanon, Indiana sites, pushing total state capital expansion commitments since 2020 to more than $21 billion.
- Lilly described the Lebanon campus as the "cornerstone of Lilly's domestic manufacturing buildout," strengthening U.S. production amid global pressure to manufacture medicines domestically rather than import them.
- The investment expands production capacity for Zepbound and Mounjaro at the Lebanon API site, while supporting future manufacturing of Foundayo and retatrutide, an investigational obesity treatment.
- Indiana Gov. Mike Braun and Mayor Matt Gentry praised the expansion, with Gentry stating, "The promise we made to strengthen our economy and provide new opportunities for our citizens is being fulfilled."
- The company is selling about $8 billion in bonds to fund this buildout, part of a broader strategy involving more than $30 billion in deals this year to diversify pipelines ahead of upcoming patent losses.
16 Articles
16 Articles
Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites - AstraZeneca (NYSE:AZN), Johnson &
Eli Lilly and Co. (NYSE:LLY) revealed plans to inject an extra $4.5 billion into two of its Indiana manufacturing sites on Wednesday. This move escalates its total capital expansion in the state since 2020 to over $21 billion. The additional funding is intended to support the production of Foundayo, Lilly’s newly approved weight-loss pill, and retatrutide, an obesity treatment in late-stage development. The new investment would introduce advance…
Eli Lilly Announces $4.5 Billion in Indiana Expansion
Pharmaceutical giant Eli Lilly and Company on May 6 announced it would invest an additional $4.5 billion in its manufacturing sites in Lebanon, Indiana. Indianapolis, Indiana-based Lilly said in a statement that its evolving drug pipeline and increasing demand for existing medicines spurred the additional capital commitment. Its newest facility, Lilly Lebanon Advanced Therapies, opened on the same day and will support clinical and commercial pro…
Indiana Capital Chronicle
communityq.comEli Lilly opening — and growing — Lebanon manufacturing site
Gov. Mike Braun, center, celebrates after cutting the ribbon at Eli Lilly's new Lilly Lebanon Advanced Therapies facility on May 6, 2026. (Photo by Niki Kelly/Indiana Capital Chronicle)Gov. Mike Braun, alongside Eli Lilly and Company leaders and employees, on Wednesday celebrated the opening of Lilly Lebanon Advanced Therapies – its first dedicated genetic medicine manufacturing facility – at a ribbon-cutting ceremony. The company also announced…
Eli Lilly announces $4.5B investment in Ind. sites, bringing total to over $21B since 2020
Eli Lilly and Company is significantly expanding its footprint in Indiana, announcing an additional $4.5 billion investment that brings its total commitment to the state to over $21 billion since 2020.
Lilly Hits $21B Indiana Investment Goal with New Lebanon Expansion
LEBANON, Ind. — Eli Lilly and Company announced a $4.5 billion expansion across its Lebanon manufacturing sites, marking a historic milestone in Indiana’s bid to lead the global life sciences industry. The announcement brings Lilly’s total capital commitment to the state to more than $21 billion since 2020. The expansion is driven by surging demand for the company’s pipeline, including its blockbuster weight-management medications and its foray …
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
